Accelus, a Palm Beach Gardens, FL-based medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, closed a $12m Series D equity financing.
The round was led by Concord Innovation Fund II, LP. Joseph Swedish, CHP Co-Founder and Partner, has also been named to Accelus’s Board of Directors.
The company intends to use the funds to drive further adoption and commercialization within the U.S. market opportunity that exists for its product portfolio of spinal implant solutions, and specifically for robotic-enabled, minimally invasive techniques, in both hospitals and ambulatory surgery centers.
Led by Chris Walsh, CEO and Co-Founder, Accelus is a medical technology company dedicated to advancing spinal surgery treatment options by developing and commercializing an ecosystem of enabling technologies, including a proprietary surgical robotic targeting and navigation platform and differentiated implant systems. Accelus offers an innovative portfolio of implants, instruments, biologics and technologies that address the clinical challenges associated with spine surgery, with a focus on minimally invasive surgery techniques and solutions. Their FlareHawk Interbody Fusion System features proprietary multidirectional expansion technology, designed for minimal disruption to the patient’s anatomy during insertion and natural load distribution and support. They also offer a Robotic-Enabled Minimally Invasive (“Remi”) robotic targeting and navigation platform which provides an efficient and economically accessible solution to a broad array of spine surgeons. The novel portfolio of implants and instruments, paired with the revolutionary robotic targeting and navigation platform, is designed to address the limitations associated with MIS procedures while providing broader access to enabling technologies for alternative facilities, such as ambulatory surgery centers.
The addition of Joseph Swedish to the Board of Directors will allow Accelus to capitalize on his deep industry knowledge and broad network of relationships to help support the company’s strategic growth. With more than 45 years of healthcare leadership experience, Mr. Swedish has served as Chairman, President and CEO for Anthem, Inc.; President and CEO for Trinity Health; President and CEO for Centura Health; and as a Division President for Hospital Corporation of America (HCA). He currently serves on the board of directors for each of CDW Corporation and International Business Machines Corporation, and has previously served in various advisory and board positions with Blue Cross Blue Shield Association, the American Hospital Association, America’s Health Insurance Plans, and Catholic Health Association.
FinSMEs
15/07/2022